Drug delivery market to reach $1.6bn
New drug delivery systems to enter healthcare over the next decade.
Read more hereNew vaccine delivery technologies for better immune response
Clinical trials show delivery of vaccines via new techniques induces greater immune responses than traditional methods.
Secure your placeSamsung Biologics and AstraZeneca expand partnership
Samsung Biologics expanded its biopharmaceutical manufacturing collaboration with AstraZeneca based on a long-term strategic deal.
View the latest programExpert Speakers to Date
- Mike Ulman
West Pharmaceutical Services - Ashwin Singhania
Ernst & Young - Donny Hoy
AstraZeneca - Stephen Framil
Merck - Twinkle Christian
Amgen - Darren Rodenhizer
Amacathera - Srini Sridharan
Bristol Myers Squibb - Deepa Arora
Clinexel Life Sciences - Alex Goraltchouk
Remedium Bio - Shubhadeep Sinha
Hetero - Jan Schnitzer
PRISM
Past attendees:
- Food and Agriculture Organization of the United Nations
- AIVITA Biomedical Inc.
- Sanofi
- Vaxcyte
- 7 Hills Pharma LLC
- IDT Biologika GmbH
- Moderna
- CEPI
- Quantoom Biosciences
- Resilience
- Vaxxinity
- myNEO
- Merck
- Repligen Corporation
Who should attend
- Drug Development
- Drug Delivery Systems
- Drug Discovery
- Biotherapeutics and Biologics
- Biotechnology Research
- Nanotechnologies
- Nano and Micro Robotics
- Modalities Research
- Molecular Medicine
- Drug Manufacturing
- Drug Formulation
- Clinical Trials
- Clinical Diagnostics
- Companion Diagnostics
- Clinical Microbiology
- System Biology and Research
- Precision Medicine
- Laboratory Equipment
- Business Development
- Clinical Trials and Approvals
- Manufacturing Research & Innovation
- Research and Development
- Strategy, Projects, & Public Affairs
- Sales and Marketing Initiatives
- Legal and Regulatory
- Equipment Certification Services
- News Reporting and Journalism
- Biotechnology Companies
- Pharmaceutical Companies
- Biosimilar Industries
- Biologics Industries
- Drug Development Companies
- Drug Discovery Companies
- Formulation Companies
- Pharma Manufacturing Companies
- Biosimilars Companies
- Generic Drugs Companies
- Medical Technology Companies
- Cosmetic Companies
- Clinical Research Organisations
- Biological Engineering Companies
- Global Healthcare Institutions
- International Quality Standards
- Associations and Alliances
- Universities and Academia
- Research and Development
- Government Agencies
- Consultants and Advisors
- Public Consultation Groups
- Legal and Compliance Services
- News Reporters and Journalists
Why Attend
The Global AMR Summit is the only event to deliver leading market intelligence and industry presentations on disrupting extracytoplasmic protein folding, anti-quorum sensing, antimicrobial photodynamic therapy, bacteriophage therapy, antimicrobial peptides, AI-based artificial antimicrobials, and various surveillance programs.
view more...Subscribe for updates:
The Premier Forum for Antimicrobial Resistance and Global Public Health
Welcome to the Global AMR Summit 2024, where global biotechnology and pharmaceutical companies will meet with leading experts and researchers in Boston, Massachusetts, to discuss the causes and response to antibiotic resistance and to understand the value of novel antibiotics to address the threat of AMR to public health.
Antimicrobial Resistance (AMR) is a serious and growing concern to global public health, with 1.5 million deaths annually. Due to the escalation of Antibiotic Resistance Pathogenic Bacteria (ARPB) and Multi-Drug Resistance (MDR) in pathogenic bacteria, public health is returning to the “pre-antibiotic era” because of the non-effectiveness of present antibiotics against bacterial infections. The lack of rapid diagnostics and poor infection prevention control has transformed AMR into a global public health threat.
Next-generation antimicrobials and vaccines to combat the ‘silent pandemic’ of antimicrobial resistance are on the priority list of global healthcare. Embracing new technologies, such as disrupting protein folding, photodynamic therapy, antimicrobial peptides, and AI-based antibiotics, will help overcome the challenges of Antimicrobial Resistance.
This year’s Global AMR Summit will become the world’s leading exhibition and conference exclusively for pharmaceutical and biotechnology companies to address scientific and business solutions in next-generation antimicrobials and vaccines to combat antimicrobial resistance.
Key topics on this year’s agenda include:
- The future of drug development and vaccines to combat infections
- New developments in protein folding to curb antimicrobial resistance
- Latest research in antimicrobial photodynamic therapy as a molecular tool
- The role of AI in the design and development of next-generation antimicrobial
- Advances in antimicrobial peptides and the development of novel antibiotics
- Global surveillance programs and stewardship platforms to control AMR
This event will provide a forum for global pharmaceutical and biotechnology stakeholders to network and build cross-market relationships to explore new technologies and technical know-how to address the challenges in antimicrobial and antimicrobial resistance.
Call for Presentation
If you would like to be a speaker at this event, please get in touch with sean.collins@iQ-Hub.com, with the subject heading “Call for Papers – Global AMR Summit 2024.”
To secure your place at the Global AMR Summit 2024, or if you need more information, please get in touch with delegates@iQ-Hub.com.
Key topics for 2024:
- The future of drug development and vaccines to combat infections
Understanding the mechanisms and drivers of antimicrobial resistance and fighting antimicrobial resistance through novel antimicrobials and vaccines. - New developments in protein folding to curb antimicrobial resistance
Explore more about the omics of antimicrobial resistance and disrupting extracytoplasmic protein folding as molecular tools to fight antimicrobial resistance. - Latest research in antimicrobial photodynamic therapy as a molecular tool
Assessing the advances in photodynamic antimicrobial chemotherapy by conjugating biomaterials with photosensitizers as a molecular tool for antimicrobial resistance. - The role of AI in the design and development of next-generation antimicrobial
Looking at the role of artificial intelligence in advancing the design and discovery of novel artificial antimicrobials. - Advances in antimicrobial peptides and the development of novel antibiotics
Achieve a deeper understanding of drug repurposing in developing novel antimicrobials, antimicrobial peptides, and quorum-sensing inhibitors as future strategies in antibacterial agent design. - Global surveillance programs and stewardship platforms to control AMR
Learn how surveillance programs and stewardship platforms can drive change in AMR and the importance of collaboration with politicians and policymakers to control AMR.
Testimonials
- Highly informational event with lots of opportunities to engage with other people from the field
Ying Wang (Johnson & Johnson) - Excellent speakers line up, showcasing the science and results from across the industry
Anne Renton (Merck) - Well organized and great discussions. Networking opportunities were excellent
Carolyn Dulney (Roche) - Provided a great learning opportunity and served as a very good networking event
Mike Zimmer (Novartis) - I loved the show! Very informative conference and a great group of people
Wensheng Du (GlaxoSmithKline) - Outstanding conference and very useful information. Well organized event and agenda was very appropriate
Barry Rosen (Sanofi)
